Available Omeprazole Strengths and Dosage Options
Standard Omeprazole Dosage Strengths
Omeprazole is primarily available in 20mg strength over the counter in the UK, which is suitable for most acid reflux symptoms. This standard dose effectively reduces stomach acid production by blocking proton pumps in the stomach lining. The 20mg capsules should be taken once daily, preferably in the morning before food, and swallowed whole with water.
When Higher Strengths May Be Needed
For severe gastro-oesophageal reflux disease (GORD) or persistent symptoms, healthcare professionals may recommend 40mg daily doses or twice-daily dosing. EverydayMeds' online consultation service allows access to prescription-strength options when over-the-counter treatments prove insufficient. Our qualified prescribers can assess your symptoms and determine appropriate dosing schedules.
Alternative PPI Options at EverydayMeds
Beyond standard omeprazole, we offer lansoprazole 15mg capsules, which may be more suitable for some patients experiencing side effects or inadequate response. Pantoprazole 20mg tablets provide another effective alternative, whilst esomeprazole offers enhanced acid suppression for severe cases. Losec MUPS 20mg tablets dissolve easily for those with swallowing difficulties.
Duration and Safety Considerations
Over-the-counter omeprazole should not be used for more than two weeks without medical supervision. Long-term use requires professional monitoring due to potential interactions and side effects. Our online consultation process ensures appropriate usage duration and monitors for any contraindications with existing medications or health conditions.
How to Purchase Through EverydayMeds
Complete our straightforward online health questionnaire to access omeprazole and other acid reflux treatments. Our UK-registered pharmacists review each consultation to ensure safe dispensing. Orders are processed quickly with discreet packaging and reliable delivery throughout the UK, making acid reflux treatment conveniently accessible.
